Phase I Trial of 5-Azacitidine Plus Gemcitabine in Patients With Advanced Pancreatic Cancer.

Trial Profile

Phase I Trial of 5-Azacitidine Plus Gemcitabine in Patients With Advanced Pancreatic Cancer.

Discontinued
Phase of Trial: Phase I

Latest Information Update: 05 Nov 2016

At a glance

  • Drugs Azacitidine (Primary) ; Gemcitabine
  • Indications Pancreatic cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 19 May 2014 According to ClinicalTrials.gov record, status changed from recruiting to discontinued.
    • 27 Feb 2013 Status changed from suspended to recruiting as reported by ClinicalTrials.gov.
    • 13 Sep 2012 Status changed from recruiting to suspended as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top